Mitochondrial Medicine – Therapeutic Development

Mitochondrial Medicine - Therapeutic Development 18 March, 2024 - 20 March, 2024

Wellcome Genome Campus, United Kingdom

Web Address


Deadline: 20/02/2024
Click here to register

Submit your abstract here

General Information

We are pleased to announce the 8th in our series of meetings on mitochondrial disorders and the search for novel effective therapies.


The conference will build new partnerships that harness our understanding of the disease mechanisms, accelerating the pace of effective treatments for mitochondrial diseases. This year’s programme will include discussions about recent discoveries on mitochondrial DNA (mtDNA) disorders to develop new therapeutic targets and the latest advances in gene editing and genomic technologies. We will also have panel discussions on how we rally the international community for clinical trial consortia and current opportunities and challenges in clinical trials.


The meeting attracts international participants interested in mitochondrial diseases, working in genomics, biochemistry, pathology and clinical medicine. The conference will bring together leaders in translational mitochondrial medicine and basic science with a programme designed to engage and inspire the next generation of mitochondrial researchers.


This conference is endorsed by European Society for Mitochondrial Research and Medicine, Mitochondrial Medicine Society and European Reference Network – Neuromuscular Diseases (EURO-NMD).

Deadline for submissions: 23 January 2023

Meeting organisers:

Wellcome Connecting Science


Keynote speakers:

  • Patrick Chinnery – University of Cambridge, UK
  • Kathrin C. Meyer – Nationwide Children’s Hospital, USA